Hantavirus Pulmonary Syndrome
Symptoms, Doctors, Treatments, Advances & More

Hantavirus Pulmonary Syndrome Overview

Save information for later
Sign Up

Learn About Hantavirus Pulmonary Syndrome

What is the definition of Hantavirus Pulmonary Syndrome?
Hantavirus pulmonary syndrome (HPS) is a severe, respiratory disease caused by infection with a hantavirus. People can become infected with a hantavirus through contact with hantavirus-infected rodents or their saliva, urine, and/or droppings. Early symptoms universally include fatigue, fever, and muscle aches (especially in the thighs, hips, and/or back), and sometimes include headaches, dizziness, chills, and abdominal problems such as nausea, vomiting, diarrhea, and pain. Later symptoms of the syndrome occur 4 to 10 days after initial onset and include coughing and shortness of breath.
What are the alternative names for Hantavirus Pulmonary Syndrome?
  • Hantavirus pulmonary syndrome
  • Four corners hantavirus
  • HARDS
  • HPS
  • Hantavirus
  • Hantavirus-associated respiratory distress syndrome
Who are the top Hantavirus Pulmonary Syndrome Local Doctors?
Elite in Hantavirus Pulmonary Syndrome
Detlev H. Kruger
Elite in Hantavirus Pulmonary Syndrome
Detlev H. Kruger
Berlin, BE, DE 

Detlev Kruger practices in Berlin, Germany. Mr. Kruger is rated as an Elite expert by MediFind in the treatment of Hantavirus Pulmonary Syndrome. His top areas of expertise are Hantavirus Pulmonary Syndrome, Hantavirus Infection, Viral Hemorrhagic Fever, and Chickenpox.

Elite in Hantavirus Pulmonary Syndrome
Peter T. Witkowski
Elite in Hantavirus Pulmonary Syndrome
Peter T. Witkowski
Berlin, BE, DE 

Peter Witkowski practices in Berlin, Germany. Mr. Witkowski is rated as an Elite expert by MediFind in the treatment of Hantavirus Pulmonary Syndrome. His top areas of expertise are Hantavirus Infection, Hantavirus Pulmonary Syndrome, Viral Hemorrhagic Fever, and Marburg Hemorrhagic Fever.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hantavirus Pulmonary Syndrome
Boris Klempa
Elite in Hantavirus Pulmonary Syndrome
Boris Klempa
Bratislava, BL, SK 

Boris Klempa practices in Bratislava, Slovakia. Mr. Klempa is rated as an Elite expert by MediFind in the treatment of Hantavirus Pulmonary Syndrome. His top areas of expertise are Hantavirus Pulmonary Syndrome, Hantavirus Infection, Omsk Hemorrhagic Fever, and Kyasanur Forest Disease.

View All Doctors
What are the latest Hantavirus Pulmonary Syndrome Clinical Trials?
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Enrollment Status: Recruiting
Publish Date: January 22, 2026

Summary: RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies. RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One Health...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Hantavirus Registry Gathers Knowledge on Epidemiology, Clinical Course, Prognostic Factors and Molecular Characteristics for Hantavirus Infections and Their Complications (HantaReg)
Hantavirus Registry Gathers Knowledge on Epidemiology, Clinical Course, Prognostic Factors and Molecular Characteristics for Hantavirus Infections and Their Complications (HantaReg)
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Other

Summary: Hantavirus disease are zoonotic infections and remain a clinical challenge with globally increasing incidence and multiple serious outbreak situations in Europe within the last years. Hantavirus disease encompasses two clinical syndromes, hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS) caused by Old World and New World hantaviruses, respectively. Dependi...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center